BillionToOne is growing in prenatal and cancer testing, but big hospital software integrations and uncertain insurance coverage could slow how fast its tests get adopted. Competition is heating up too, so the company may need to spend more to keep pace, even if the long-term demand for these tests stays strong.Read more
BillionToOne rides two big healthcare trends: easier, safer pregnancy screening and blood-based cancer testing that doctors can use to guide treatment. Wider insurance coverage and smoother hospital ordering could lift demand, but tougher competition and uncertain payer decisions could still slow the story down.Read more
BillionToOne is riding a shift toward more personalized care, as hospitals and doctors lean on simple blood tests to guide pregnancy and cancer decisions and insurers increasingly agree to pay for them. The upside comes from wider adoption through big health-system software rollouts and a major drug-company partnership, but the story can break if coverage decisions stall or rivals catch up.Read more
No trending discussion available.
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a methylation-based assay that quantifies the amount of cancer at the single molecule level without requiring a tissue biopsy, enabling real-time monitoring of patient response to therapy with unprecedented precision. BillionToOne, Inc. was incorporated in 2016 and is headquartered in Menlo Park, California.
